Recent developments in next-generation occlusion devices

Cheng Lin1, Liwu Liu1, Yanju Liu1

  • 1Department of Astronautical Science and Mechanics, Harbin Institute of Technology (HIT), P.O. Box 301, No. 92 West Dazhi Street, Harbin 150001, People's Republic of China.

Acta Biomaterialia
|May 8, 2021
PubMed

Insights

Next-generation biodegradable and 3D-printed heart occlusion devices offer safer, minimally invasive alternatives to traditional treatments for congenital heart defects and stroke prevention. These advanced devices promise improved biocompatibility and reduced complications compared to conventional Nitinol occluders.

Area of Science:

  • Cardiovascular Medicine
  • Biomaterials Science
  • Medical Device Engineering

Background:

  • Transcatheter closure is a key treatment for congenital heart defects (CHDs) and left atrial appendage (LAA) issues.
  • Conventional Nitinol-based occlusion devices face complications like erosion and displacement.
  • Minimally invasive approaches are replacing open-heart surgery and long-term medication.

Purpose of the Study:

  • To comprehensively review next-generation occlusion devices for treating CHDs and LAA.
  • To focus on advancements in materials, configurations, and manufacturing methods.
  • To discuss challenges and future directions in occlusion device technology.

Main Methods:

  • Review of current literature on novel occlusion devices.
  • Analysis of biodegradable and 3D-printed device technologies.
  • Examination of deployment strategies and available clinical data.

Main Results:

  • Next-generation devices, including biodegradable and 3D-printed options, show promise as alternatives to Nitinol devices.
  • These novel devices offer improved biocompatibility, customization, and reduced complication risks.
  • Intelligent materials and rapid manufacturing methods like 3D/4D printing are emerging.

Conclusions:

  • Next-generation occlusion devices represent a significant advancement in treating heart conditions minimally invasively.
  • Biodegradable and customized devices are poised to reduce complications and improve patient outcomes.
  • Further research and clinical validation are needed to fully realize the potential of these innovative technologies.

Related Concept Videos

Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
919
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
788
Non-ohmic Devices00:51

Non-ohmic Devices

In most substances, the current flow is proportional to the voltage applied to it. A simple relationship between the values of current, voltage, and resistance is known as Ohm's law. Nonohmic devices do not exhibit a linear relationship between voltage and current. One such device is the semiconducting circuit element known as a diode. A diode is a circuit device that allows current flow in only one direction.
Consider a simple circuit consisting of a battery, a diode, and a resistor. A...
1.2K